“…The confirmation rates for breast or ovarian cancer, rheumatoid or psoriatic arthritis or psoriasis, MS, and vasculitis PPRNs were 72%, 50%, 75%, and 67%, respectively, which increased to 91%, 67%, 93%, and 80%, respectively, when limiting the cohort to those with continuous health plan enrollment ≥5 years. …”